These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma. Kuroda T; Ogiwara H; Sasaki M; Takahashi K; Yoshida H; Kiyokawa T; Sudo K; Tamura K; Kato T; Okamoto A; Kohno T Gynecol Oncol; 2019 Dec; 155(3):489-498. PubMed ID: 31604667 [TBL] [Abstract][Full Text] [Related]
24. The molecular mechanisms of XBP-1 gene silencing on IRE1α-TRAF2-ASK1-JNK pathways in oral squamous cell carcinoma under endoplasmic reticulum stress. Chen H; Yang H; Pan L; Wang W; Liu X; Ren X; Liu Y; Liu W; Zhang Y; Jiang L; Li K; Zhang B; Wang LX Biomed Pharmacother; 2016 Feb; 77():108-13. PubMed ID: 26796273 [TBL] [Abstract][Full Text] [Related]
25. Adaptive endoplasmic reticulum stress signalling via IRE1α-XBP1 preserves self-renewal of haematopoietic and pre-leukaemic stem cells. Liu L; Zhao M; Jin X; Ney G; Yang KB; Peng F; Cao J; Iwawaki T; Del Valle J; Chen X; Li Q Nat Cell Biol; 2019 Mar; 21(3):328-337. PubMed ID: 30778220 [TBL] [Abstract][Full Text] [Related]
26. SWI/SNF catalytic subunits' switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells. Wu S; Fatkhutdinov N; Fukumoto T; Bitler BG; Park PH; Kossenkov AV; Trizzino M; Tang HY; Zhang L; Gardini A; Speicher DW; Zhang R Nat Commun; 2018 Oct; 9(1):4116. PubMed ID: 30297712 [TBL] [Abstract][Full Text] [Related]
27. Genome-wide DNA methylation in relation to ARID1A deficiency in ovarian clear cell carcinoma. Li S; Meersma GJ; Kupryjanczyk J; de Jong S; Wisman GBA J Transl Med; 2024 Jun; 22(1):556. PubMed ID: 38858765 [TBL] [Abstract][Full Text] [Related]
28. The unfolded protein response components IRE1α and XBP1 promote human coronavirus infection. Oda JM; den Hartigh AB; Jackson SM; Tronco AR; Fink SL mBio; 2023 Aug; 14(4):e0054023. PubMed ID: 37306512 [TBL] [Abstract][Full Text] [Related]
30. RITA enhances irradiation-induced apoptosis in p53-defective cervical cancer cells via upregulation of IRE1α/XBP1 signaling. Zhu H; Abulimiti M; Liu H; Su XJ; Liu CH; Pei HP Oncol Rep; 2015 Sep; 34(3):1279-88. PubMed ID: 26134873 [TBL] [Abstract][Full Text] [Related]
32. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice. Liu X; Guo GL; Kong B; Hilburn DB; Hubchak SC; Park S; LeCuyer B; Hsieh A; Wang L; Fang D; Green RM Hepatology; 2018 Jul; 68(1):304-316. PubMed ID: 29377207 [TBL] [Abstract][Full Text] [Related]
33. IRE1α-XBP1 is a novel branch in the transcriptional regulation of Ucp1 in brown adipocytes. Asada R; Kanemoto S; Matsuhisa K; Hino K; Cui M; Cui X; Kaneko M; Imaizumi K Sci Rep; 2015 Nov; 5():16580. PubMed ID: 26568450 [TBL] [Abstract][Full Text] [Related]
34. IRE1α/XBP1-mediated branch of the unfolded protein response regulates osteoclastogenesis. Tohmonda T; Yoda M; Iwawaki T; Matsumoto M; Nakamura M; Mikoshiba K; Toyama Y; Horiuchi K J Clin Invest; 2015 Aug; 125(8):3269-79. PubMed ID: 26193638 [TBL] [Abstract][Full Text] [Related]
36. Emodin, an Emerging Mycotoxin, Induces Endoplasmic Reticulum Stress-Related Hepatotoxicity through IRE1α-XBP1 Axis in HepG2 Cells. Park SB; Cho GH; Park YE; Chun HS Toxins (Basel); 2023 Jul; 15(7):. PubMed ID: 37505724 [TBL] [Abstract][Full Text] [Related]
37. Mechanism of the induction of endoplasmic reticulum stress by the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT): Activation of PERK/eIF2α, IRE1α, ATF6 and calmodulin kinase. Merlot AM; Shafie NH; Yu Y; Richardson V; Jansson PJ; Sahni S; Lane DJR; Kovacevic Z; Kalinowski DS; Richardson DR Biochem Pharmacol; 2016 Jun; 109():27-47. PubMed ID: 27059255 [TBL] [Abstract][Full Text] [Related]
38. Novel mechanism of enhancing IRE1α-XBP1 signalling via the PERK-ATF4 pathway. Tsuru A; Imai Y; Saito M; Kohno K Sci Rep; 2016 Apr; 6():24217. PubMed ID: 27052593 [TBL] [Abstract][Full Text] [Related]
39. Positive contribution of IRE1α-XBP1 pathway to the expression of placental cathepsins. Oikawa D; Iwawaki T Biochem Biophys Res Commun; 2013 Apr; 433(4):426-31. PubMed ID: 23541586 [TBL] [Abstract][Full Text] [Related]
40. Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib. Miller RE; Brough R; Bajrami I; Williamson CT; McDade S; Campbell J; Kigozi A; Rafiq R; Pemberton H; Natrajan R; Joel J; Astley H; Mahoney C; Moore JD; Torrance C; Gordan JD; Webber JT; Levin RS; Shokat KM; Bandyopadhyay S; Lord CJ; Ashworth A Mol Cancer Ther; 2016 Jul; 15(7):1472-84. PubMed ID: 27364904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]